Page last updated: 2024-10-24

candesartan cilexetil and Asymmetric Diabetic Proximal Motor Neuropathy

candesartan cilexetil has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 1 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Research Excerpts

ExcerptRelevanceReference
"The effect of the angiotensin II receptor blocker, candesartan cilexetil, on proteinuria was examined in a prospective, multicenter, randomized, double-blind study in Japanese subjects with type 2 diabetes."5.11Antiproteinuric effect of candesartan cilexetil in Japanese subjects with type 2 diabetes and nephropathy. ( Haneda, M; Kawamori, R; Kikkawa, R; Sakai, H, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haneda, M1
Kikkawa, R1
Sakai, H1
Kawamori, R1

Trials

1 trial available for candesartan cilexetil and Asymmetric Diabetic Proximal Motor Neuropathy

ArticleYear
Antiproteinuric effect of candesartan cilexetil in Japanese subjects with type 2 diabetes and nephropathy.
    Diabetes research and clinical practice, 2004, Volume: 66, Issue:1

    Topics: Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Creatinine; Diabetes Mellitus,

2004